Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free BOY Stock Alerts

Bodycote (BOY) Stock Chart & Stock Price History

Bodycote logo
GBX 699.33 +10.83 (+1.57%)
As of 12:27 PM Eastern
Compare

Bodycote Stock Price Performance

The Bodycote (BOY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 22.91%, with a year-to-date return of 0.19%. In the past month, the stock has increased 0.33%, reflecting recent market activity.

As of the latest close, Bodycote traded at GBX 684.89 with a market cap of £1.17 billion and volume of 384,737 shares. Five years ago, the stock traded at GBX 818, representing a 14.51% decrease over that period. At the time, it had a market cap of £1.57 billion and a volume of 382,950 shares.

Receive BOY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bodycote and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.46%
1 Month
Performance
+0.33%
3 Month
Performance
-9.82%
Year-To-Date
Performance
+0.19%
1 Year
Performance
+22.91%
5 Year
Performance
-14.51%

BOY Stock Chart for Thursday, May, 14, 2026

BOY Chart by TradingView

Bodycote Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 681GBX 684.89
+0.57%		GBX 699.50GBX 675384,737 shs£1.17 billion
05/12/2026GBX 705GBX 681
-3.40%		GBX 699.50GBX 679.76331,268 shs£1.16 billion
05/11/2026GBX 702.56GBX 705
+0.35%		GBX 715GBX 695.50354,656 shs£1.21 billion
05/08/2026GBX 705GBX 702.56
-0.35%		GBX 707.50GBX 697.50149,534 shs£1.20 billion
05/07/2026GBX 702.50GBX 705
+0.36%		GBX 719.50GBX 704.50300,145 shs£1.21 billion
05/06/2026GBX 668.04GBX 702.50
+5.16%		GBX 702.50GBX 678989,403 shs£1.20 billion
05/05/2026N/AGBX 668.04GBX 677GBX 662531,225 shs£1.15 billion
04/30/2026GBX 683.50GBX 681
-0.37%		GBX 684GBX 662145,355 shs£1.17 billion
04/29/2026GBX 689.50GBX 683.50
-0.87%		GBX 699GBX 683.50384,524 shs£1.17 billion
04/28/2026GBX 690.73GBX 689.50
-0.18%		GBX 696GBX 686.50296,874 shs£1.18 billion
04/27/2026GBX 695GBX 690.73
-0.61%		GBX 704GBX 682294,314 shs£1.18 billion
04/24/2026GBX 701.50GBX 695
-0.93%		GBX 724GBX 690195,143 shs£1.19 billion
04/23/2026GBX 702GBX 701.50
-0.07%		GBX 711.50GBX 690.50413,606 shs£1.20 billion
04/22/2026GBX 704.50GBX 702
-0.35%		GBX 722.50GBX 70016.53 million shs£1.20 billion
04/21/2026GBX 701GBX 704.50
+0.50%		GBX 715GBX 70012.30 million shs£1.21 billion
04/20/2026GBX 721.50GBX 701
-2.84%		GBX 722GBX 701150,604 shs£1.20 billion
04/17/2026GBX 699GBX 721.50
+3.22%		GBX 728.50GBX 695.509.52 million shs£1.24 billion
04/16/2026GBX 691.50GBX 699
+1.08%		GBX 703.50GBX 688.506.28 million shs£1.20 billion
04/15/2026GBX 697GBX 691.50
-0.79%		GBX 699.50GBX 688525,149 shs£1.19 billion
04/14/2026GBX 683.50GBX 697
+1.98%		GBX 705GBX 685.50299,316 shs£1.19 billion
04/13/2026GBX 691GBX 683.50
-1.09%		GBX 687GBX 679369,017 shs£1.17 billion
Related Companies

This page (LON:BOY) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The Rare Earth Shift Few Saw Coming
Rare earth elements are the hidden backbone of electric vehicles, modern defense technology, and advanced elec...
i2i Marketing Group, LLC | Sponsoredtc pixel
You'll buy SpaceX at $1.75 trillion. Insiders bought at $20 billion.
Insiders bought SpaceX at $20 billion. Banks got in at $100 billion. By the time it hits your brokerage accoun...
Behind the Markets | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel